Search

Christopher R. Stone

Examiner (ID: 15088, Phone: (571)270-3494 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1609, 1628, 4173, 1614
Total Applications
750
Issued Applications
250
Pending Applications
42
Abandoned Applications
457

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18314117 [patent_doc_number] => 11628177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => Compositions and methods for deep dermal drug delivery [patent_app_type] => utility [patent_app_number] => 17/527856 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10091 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527856 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/527856
Compositions and methods for deep dermal drug delivery Nov 15, 2021 Issued
Array ( [id] => 19083031 [patent_doc_number] => 20240109832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => RAPID CONSTRUCTION OF TETRALIN, CHROMANE, AND INDANE MOTIFS VIA CYCLATIVE C-H/C-H COUPLING: FOUR-STEP TOTAL SYNTHESIS OF (+-)-RUSSUJAPONOL F [patent_app_type] => utility [patent_app_number] => 18/252655 [patent_app_country] => US [patent_app_date] => 2021-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252655 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/252655
RAPID CONSTRUCTION OF TETRALIN, CHROMANE, AND INDANE MOTIFS VIA CYCLATIVE C-H/C-H COUPLING: FOUR-STEP TOTAL SYNTHESIS OF (+-)-RUSSUJAPONOL F Nov 8, 2021 Pending
Array ( [id] => 17913172 [patent_doc_number] => 20220315567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Substituted Ureas and Methods of Making and Using Same [patent_app_type] => utility [patent_app_number] => 17/520350 [patent_app_country] => US [patent_app_date] => 2021-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520350 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/520350
Substituted Ureas and Methods of Making and Using Same Nov 4, 2021 Abandoned
Array ( [id] => 18733412 [patent_doc_number] => 11802135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Lysophosphatidic acid derivative [patent_app_type] => utility [patent_app_number] => 17/518212 [patent_app_country] => US [patent_app_date] => 2021-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 59315 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518212 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/518212
Lysophosphatidic acid derivative Nov 2, 2021 Issued
Array ( [id] => 18747052 [patent_doc_number] => 11806341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Methods of diagnosing and treating anxiety disorder [patent_app_type] => utility [patent_app_number] => 17/512827 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 46 [patent_no_of_words] => 55801 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512827 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/512827
Methods of diagnosing and treating anxiety disorder Oct 27, 2021 Issued
Array ( [id] => 17576847 [patent_doc_number] => 20220133702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE [patent_app_type] => utility [patent_app_number] => 17/513060 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12555 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513060 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/513060
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Oct 27, 2021 Abandoned
Array ( [id] => 18747051 [patent_doc_number] => 11806340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Methods of diagnosing and treating conduct disorder [patent_app_type] => utility [patent_app_number] => 17/511795 [patent_app_country] => US [patent_app_date] => 2021-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 46 [patent_no_of_words] => 59779 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511795 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/511795
Methods of diagnosing and treating conduct disorder Oct 26, 2021 Issued
Array ( [id] => 19091063 [patent_doc_number] => 11952495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-04-09 [patent_title] => Fluorogenic pH-sensitive compounds and their methods of use [patent_app_type] => utility [patent_app_number] => 17/498377 [patent_app_country] => US [patent_app_date] => 2021-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 57 [patent_no_of_words] => 29158 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498377 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/498377
Fluorogenic pH-sensitive compounds and their methods of use Oct 10, 2021 Issued
Array ( [id] => 20206358 [patent_doc_number] => 20250276078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => Camptothecin Derivative And Ligand-drug Conjugate Thereof [patent_app_type] => utility [patent_app_number] => 18/030754 [patent_app_country] => US [patent_app_date] => 2021-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11634 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030754 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030754
Camptothecin Derivative And Ligand-drug Conjugate Thereof Oct 8, 2021 Pending
Array ( [id] => 18995864 [patent_doc_number] => 11912691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Tocotrienols derivates, methods and uses thereof [patent_app_type] => utility [patent_app_number] => 18/030775 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 8679 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030775 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030775
Tocotrienols derivates, methods and uses thereof Oct 7, 2021 Issued
Array ( [id] => 18769240 [patent_doc_number] => 20230363996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => HAIR CARE COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/029734 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029734 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/029734
HAIR CARE COMPOSITION Oct 4, 2021 Pending
Array ( [id] => 18806827 [patent_doc_number] => 20230381160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => PROPHYLATIC USE OF CALCIUM CHANNEL BLOCKERS IN TUBERCULOSIS [patent_app_type] => utility [patent_app_number] => 18/028233 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4688 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028233 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/028233
PROPHYLATIC USE OF CALCIUM CHANNEL BLOCKERS IN TUBERCULOSIS Sep 23, 2021 Pending
Array ( [id] => 18056221 [patent_doc_number] => 20220387307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => METHOD OF TREATING DISEASE [patent_app_type] => utility [patent_app_number] => 17/479780 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479780 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479780
METHOD OF TREATING DISEASE Sep 19, 2021 Abandoned
Array ( [id] => 17333781 [patent_doc_number] => 20220000112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT [patent_app_type] => utility [patent_app_number] => 17/476407 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18970 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476407 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/476407
DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT Sep 14, 2021 Abandoned
Array ( [id] => 19914730 [patent_doc_number] => 12290073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-06 [patent_title] => Anti-microbial compound and methods of use [patent_app_type] => utility [patent_app_number] => 17/447446 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 13670 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447446 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/447446
Anti-microbial compound and methods of use Sep 12, 2021 Issued
Array ( [id] => 17441692 [patent_doc_number] => 20220062197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => 7-OH-CANNABIDIOL (7-OH-CBD) AND/OR 7-OH-CANNABIDIVARIN (7-OH-CBDV) FOR USE IN THE TREATMENT OF EPILEPSY [patent_app_type] => utility [patent_app_number] => 17/472000 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472000 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472000
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy Sep 9, 2021 Issued
Array ( [id] => 17460176 [patent_doc_number] => 20220073481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => BIMETAL OXIDE CATALYST AND METHODS [patent_app_type] => utility [patent_app_number] => 17/472243 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472243 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472243
Bimetal oxide catalyst and methods Sep 9, 2021 Issued
Array ( [id] => 18384464 [patent_doc_number] => 11655232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-23 [patent_title] => Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione [patent_app_type] => utility [patent_app_number] => 17/465668 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 54 [patent_no_of_words] => 10496 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465668 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465668
Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Sep 1, 2021 Issued
Array ( [id] => 18656113 [patent_doc_number] => 20230301988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/023661 [patent_app_country] => US [patent_app_date] => 2021-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023661 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023661
INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF Aug 25, 2021 Pending
Array ( [id] => 18692413 [patent_doc_number] => 20230322647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => PCNHCP METAL COMPLEXES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/042752 [patent_app_country] => US [patent_app_date] => 2021-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16889 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042752 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042752
PC Aug 21, 2021 Issued
Menu